Skip to main content
Clinical Trials/NCT04837742
NCT04837742
Completed
Not Applicable

The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy

National Taiwan University Hospital1 site in 1 country30 target enrollmentApril 14, 2021

Overview

Phase
Not Applicable
Intervention
ESPB group
Conditions
Hepatocellular Carcinoma
Sponsor
National Taiwan University Hospital
Enrollment
30
Locations
1
Primary Endpoint
Visual analogue pain scale at postoperative day one
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is a double blind, randomized controlled trial to evaluate the efficacy of ESPB(Erector Spinae Plane Block) on postoperative analgesia in RFA( Radiofrequency Ablation therapy). We will include 80 patients, and randomly assign to ESPB(Chirocaine) group and control group(normal saline).We deduce Erector spinae plane block can be use as a postoperative analgesic way for patients who receive radiofrequency ablation of hepatocellular carcinoma.

Detailed Description

Computed tomography guided radiofrequency ablation of hepatocellular carcinoma(HCC) has became a popular way to treat HCC. Although the wound is small and the patients can discharge on the next day, they have to suffer from moderate to severe pain. Nowadays Erector spinae plane block has been applied to many surgery as a postoperative analgesic strategy. We deduce Erector spinae plane block can be use as a postoperative analgesic way for patients who receive radiofrequency ablation of hepatocellular carcinoma. Besides, we will add contrast medium to evaluate the spread area of local anesthetics.

Registry
clinicaltrials.gov
Start Date
April 14, 2021
End Date
January 18, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

ESPB group

ESPB injection at T10 region with levobupivacaine 100mg (20 ml)+ Omnipaque10 ml

Intervention: ESPB group

Control group

ESPB injection at T10 region with 0.9% normal saline 20ml + Omnipaque10ml

Intervention: Control group

Outcomes

Primary Outcomes

Visual analogue pain scale at postoperative day one

Time Frame: approximately 12-24 hrs

We will assess the pain intensity by using a 100-mm visual analogue scale at postoperative day one

Drug spread level of erector spinae plane block

Time Frame: approximately 2-3 hrs

We will assess the numbers of vertebral levels of erector spinae block drug spreading by using computed tomography

Secondary Outcomes

  • Postoperative recovery quality(approximately 2 days)
  • Visual analogue pain scale at post-anesthesia care unit(approximately 3 hours)

Study Sites (1)

Loading locations...

Similar Trials